Condition
Seizure, Epileptic
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting2
Withdrawn1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06836687RecruitingPrimary
Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure
NCT06143241Not ApplicableCompleted
Cognitive Function and Glymphatic System in Children with Epilepsy
NCT05459597RecruitingPrimary
Antiepileptic Drugs in Elderly Patients
NCT02968966Phase 2WithdrawnPrimary
Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies
Showing all 4 trials